文献速递瓣膜病与结构性心脏病血脂与心血管预防

脂蛋白(a)与氧化磷脂促进主动脉瓣狭窄患者的瓣膜钙化

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究合并2个前瞻性队列,在145例主动脉瓣狭窄(Vmax>2.0 m/s)患者中测定Lp(a)与OxPL-apoB水平,并结合18F-NaF PET、CT钙评分与超声随访。结果显示基线Lp(a)最高三分位者瓣膜钙化活性更高、钙化与血流动力学进展更快,主动脉瓣置换与死亡风险增加(HR 1.87,95%CI 1.13–3.08,p=0.014);体外实验中Lp(a)经OxPL介导促进瓣膜间质细胞成骨分化。

要点

  • Lp(a)最高三分位者18F-NaF瓣膜钙化活性更高(2.16 vs 1.97,p=0.043)。
  • Lp(a)最高三分位者CT钙化进展更快(309 vs 93 AU/年,p=0.015)。
  • Lp(a)/OxPL或为延缓主动脉瓣狭窄进展的干预靶点。

核心结论

  • 在主动脉瓣狭窄患者中,Lp(a)与OxPL驱动瓣膜钙化和疾病进展,降低Lp(a)或灭活OxPL可能延缓AS进展。

研究设计与样本

  • 合并2个前瞻性队列,共145例主动脉瓣狭窄患者(Vmax>2.0 m/s;68%男性;年龄70.3±9.9岁),行基线18F-NaF PET、重复CT钙评分与重复超声心动图,并开展体外瓣膜间质细胞实验。

主要发现

  • 基线Lp(a)最高三分位者18F-NaF最病变段组织本底比为2.16 vs 1.97(n=79,p=0.043)。
  • 随访中最高三分位者CT钙评分进展为309 AU/年(IQR 142–483)vs 93 AU/年(IQR 56–296)(n=51,p=0.015)。
  • 超声血流动力学进展为0.23±0.20 m/s/年 vs 0.14±0.20 m/s/年(n=129,p=0.019)。
  • 主动脉瓣置换与死亡风险HR 1.87(95%CI 1.13–3.08,p=0.014)(n=145);OxPL-apoB结果类似。
  • 体外Lp(a)经OxPL介导促进瓣膜间质细胞成骨分化,可被抗OxPL单克隆抗体E06抑制。

临床怎么用

  • 对主动脉瓣狭窄患者,Lp(a)与OxPL-apoB水平可能有助于评估钙化进展与临床事件风险。
  • 上述结果为降低Lp(a)或灭活OxPL作为治疗靶点提供了依据,尚需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lipoprotein(a) [Lp(a)], a major carrier of oxidized phospholipids (OxPL), is associated with an increased incidence of aortic stenosis (AS). However, it remains unclear whether elevated Lp(a) and OxPL drive disease progression and are therefore targets for therapeutic intervention. OBJECTIVES: This study investigated whether Lp(a) and OxPL on apolipoprotein B-100 (OxPL-apoB) levels are associated with disease activity, disease progression, and clinical events in AS patients, along with the mechanisms underlying any associations. METHODS: This study combined 2 prospective cohorts and measured Lp(a) and OxPL-apoB levels in patients with AS (Vmax >2.0 m/s), who underwent baseline 18F-sodium fluoride (18F-NaF) positron emission tomography (PET), repeat computed tomography calcium scoring, and repeat echocardiography. In vitro studies investigated the effects of Lp(a) and OxPL on valvular interstitial cells. RESULTS: Overall, 145 patients were studied (68% men; age 70.3 ± 9.9 years). On baseline positron emission tomography, patients in the top Lp(a) tertile had increased valve calcification activity compared with those in lower tertiles (n = 79; 18F-NaF tissue-to-background ratio of the most diseased segment: 2.16 vs. 1.97; p = 0.043). During follow-up, patients in the top Lp(a) tertile had increased progression of valvular computed tomography calcium score (n = 51; 309 AU/year [interquartile range: 142 to 483 AU/year] vs. 93 AU/year [interquartile range: 56 to 296 AU/year; p = 0.015), faster hemodynamic progression on echocardiography (n = 129; 0.23 ± 0.20 m/s/year vs. 0.14 ± 0.20 m/s/year] p = 0.019), and increased risk for aortic valve replacement and death (n = 145; hazard ratio: 1.87; 95% CI: 1.13 to 3.08; p = 0.014), compared with lower tertiles. Similar results were noted with OxPL-apoB. In vitro, Lp(a) induced osteogenic differentiation of valvular interstitial cells, mediated by OxPL and inhibited with the E06 monoclonal antibody against OxPL. CONCLUSIONS: In patients with AS, Lp(a) and OxPL drive valve calcification and disease progression. These findings suggest lowering Lp(a) or inactivating OxPL may slow AS progression and provide a rationale for clinical trials to test this hypothesis.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Zheng KH, Tsimikas S, Pawade T, et al. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. J Am Coll Cardiol. 2019. PMID: 31047003. doi:10.1016/j.jacc.2019.01.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。